Delivery Order SPE2DB24D2205-SPE2DB24FDUSG

Award Date 5/28/24
Potential Completion Date 5/29/24
Potential Value $39K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award, valued at $12,164.72, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The award is for the delivery of 4564804512 - CARVEDILOL ER 20 MG CAPSULE 30S, a prescription medication. Amerisourcebergen, a large pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,496.16 firm fixed price delivery order is for 4566833305 - CARVEDILOL ER 20 MG CAPSULE 30S. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the provision of 4565726170 ! CARVEDILOL ER 20 MG CAPSULE 30S. The contract, valued at $3,023.68, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) and does not have a set-aside designation. The contract has an ultimate completion date of September 10, 2024. Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $6,015.70 Firm Fixed Price order is for the delivery of 4564912460 CARVEDILOL ER 80 MG CAPSULE 30S, and has a completion date of June 17, 2024. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC allows the DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Carvedilol ER 20 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $14,490.78 and an ultimate completion date of June 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $5,142.91 firm-fixed-price delivery order is for the supply of 4565665269 CARVEDILOL ER 20 MG CAPSULE 30S, a generic pharmaceutical product. The contract has an ultimate completion date of September 4, 2024. Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,589.07 firm fixed price delivery order is for CARVEDILOL ER 40 MG CAPSULE 30S, a cardiovascular medication. The contract has an ultimate completion date of January 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4556203771 - CARVEDILOL ER 20 MG CAPSULE 30S, with a ceiling value of $1,401.24. It is a Delivery Order issued under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of CARVEDILOL ER 40 MG CAPSULE 30S to the Defense Logistics Agency (DLA), a defense agency. The fixed-price delivery order has a ceiling value of $1,164.05 and an ultimate completion date of June 20, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award is for $67,695.59 and was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566584366 - CARVEDILOL ER 40 MG CAPSULE 30S, a cardiovascular medication. It is a firm fixed-price delivery order with a completion date of December 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDUSG
    Delivery Order

This federal contract award, valued at $38,704.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564730538 - CARVEDILOL ER 20 MG CAPSULE 30S, with a final completion date of May 29, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award was not designated as a set-aside.

Generated 8/27/24, 9:30 AM